CYP 269 (Guaifenesin and Phenylephrine 600 mg / 20 mg)

Pill imprint CYP 269 has been identified as Guaifenesin and phenylephrine hydrochloride 600 mg / 20 mg.

Guaifenesin/phenylephrine is used in the treatment of cough and nasal congestion; sinus symptoms and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/phenylephrine 600 mg / 20 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for CYP 269

Guaifenesin and phenylephrine hydrochloride 600 mg / 20 mg CYP 269  Front
Guaifenesin and phenylephrine hydrochloride 600 mg / 20 mg CYP 269  Back
Guaifenesin and phenylephrine hydrochloride
Imprint:
CYP 269
Strength:
600 mg / 20 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Rx and/or OTC
Drug Class:
Upper respiratory combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Cypress Pharmaceutical Inc

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)